For years, medtech manufacturers tweaked their current products, added a few, bells and whistles, and slapped on a price premium and called it innovation.
With the move to value-based care, those days are well behind us as Stryker’s CEO , Kevin Lobo, has himself acknowledged. For the past several years, the orthopedics industry is under tremendous pricing pressure and companies have consolidated and made other market adjustments to remain competitive.
And yet two very different visions of the future of orthopedics seems to be emerging, especially with Medtronic revealing that it has bought an Twin Cities hip and knee implant maker for an undisclosed amount to enter the space. What are they?